Life Settlement

A life settlement is a transaction in which a policyholder sells an existing, in-force life insurance policy to a third-party investor for cash. The buyer assumes responsibility for future premium payments and receives the full death benefit when the insured dies. It sits between surrender (cashing out with the insurer) and keeping the policy, offering substantially more than surrender value but requiring the policyholder to give up the death benefit.

The scenario and the appeal

Imagine a 75-year-old who bought a $500,000 whole life policy 20 years ago to provide for a spouse. The spouse is now financially secure. The policyholder needs cash more than a death benefit—medical expenses, debt, or lifestyle change. Surrendering the policy to the insurer yields $150,000 of cash value. But a life settlement firm might offer $350,000.

For someone in poor health or advanced age, the gap is enormous. The settlement firm values the policy based on life expectancy: if actuaries believe the insured is likely to die within 5–10 years, the death benefit (which the firm will eventually collect) is nearly certain. That certainty is worth paying 60–80% of face value today.

The policyholder walks away with a large check immediately, no longer owes premiums, and sacrifices only a death benefit that may have become less central to their financial plan. For many retirees, this is a rational choice.

How the market works

Life settlements are transacted through specialized settlement firms, brokers, and some insurance professionals. The process typically unfolds as follows:

1. Solicitation: Settlement firms identify candidates (elderly policyholders, those with chronic illness, or those holding expensive policies they no longer need).
2. Underwriting: The buyer orders a medical exam and investigates the policy to confirm it is legitimate and in force.
3. Valuation: Actuaries calculate life expectancy and apply a discount to the death benefit based on the buyer’s required return.
4. Offer: The firm presents a cash offer, typically 50–80% of the death benefit.
5. Closing: If the policyholder accepts, the policy is formally assigned to the buyer. The buyer pays the policyholder and assumes all future premium payments.

Institutional buyers—hedge funds, pension funds, and life settlement investment firms—hold portfolios of purchased policies, aggregating mortality risk. Over time, as policyholders die, the funds collect the death benefits, realizing returns.

Pricing: more than surrender, less than face value

A $500,000 death benefit policy with $150,000 of cash value will command a surrender offer of $150,000 from the insurer. A settlement firm might offer $250,000–$380,000, depending on the insured’s age, health, and life expectancy.

The buyer’s math is straightforward: if the insured is expected to live 7 more years, and premiums total $35,000 annually ($245,000 in total future costs), then paying $350,000 today for a $500,000 benefit 7 years hence yields a 6–8% annual return, assuming no defaults. That return profile attracts institutional capital.

If the insured lives longer than expected, the buyer’s return shrinks. If the insured dies sooner, returns spike. Settlement firms invest in medical underwriting and actuarial analysis to manage this longevity risk.

Tax consequences

Proceeds from a life settlement are generally taxed as capital gains. If you sell a policy for $350,000 and your cost basis (total premiums paid) is $200,000, the $150,000 gain is long-term capital gain if you held the policy for more than one year, which most sellers have.

However, if the insured is chronically ill or terminally ill (a category that may qualify for viatical settlements), some of the gain may be excluded from tax under Section 101(g) of the Internal Revenue Code. The rules are complex and depend on the insured’s medical prognosis and whether the buyer is a licensed viatical or life settlement provider.

Professional tax and legal advice is essential before closing a settlement; many policyholders are surprised by the tax bill.

Contrast with viatical settlements

A viatical settlement is a special case of life settlement reserved for the terminally ill (typically life expectancy under 2 years). Pricing is much higher—often 70–95% of the death benefit—because death is imminent and near-certain. The insured may also qualify for preferential tax treatment.

A standard life settlement can apply to healthy elderly policyholders (65+) or those with chronic conditions; pricing reflects longer expected survival and lower certainty of near-term claims.

The dark side: stranger-originated life insurance

The life settlement market has been plagued by stranger-originated life insurance (STOLI) schemes, in which unethical parties sold policies to unsuspecting elderly people specifically to acquire them for settlement. This practice is now largely prohibited by law, but it highlights the ethical boundaries of the secondary market. Legitimate settlement firms require clear underwriting and policy ownership history.

Who should consider it

Life settlements appeal to:

• Retirees holding large policies they no longer need, who want to monetize the benefit without the haircut of surrender.
• Those with limited liquidity who have insurance but more urgent uses for capital.
• Individuals in declining health for whom the death benefit has become unlikely to be claimed (from their perspective).

Life settlements do not make sense for:

• Young, healthy policyholders (returns to buyers would be poor, and offers will be very low).
• Those with genuine dependents relying on the death benefit.
• Sellers who can afford to keep the policy and leave a larger estate.

See also